Clinical Trials List
2019-07-22 - 2026-12-29
Phase III
Recruiting7
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 王中傑 Division of Others
- YI-KAI CHANG Division of Urology
- CHING-CHU LU Division of Nuclear Medicine
- SHUO-MENG WANG Division of Urology
- - - Division of Radiology
- JIAN-HUA HONG Division of Urology
- PO-MING CHOW Division of Urology
- YU-CHUAN LU Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Cheng-Kuang Yang Division of Urology
- 盧嘉文 Division of Urology
- Jian-Ri Li Division of Urology
- Chuan-Shu Chen Division of Urology
- 王樹吉 Division of Urology
- 熊小澐 Division of Radiology
- 裘坤元 Division of Urology
- 洪晟鈞 Division of Urology
- 洪啟峰 Division of Urology
- Chia-Yen Lin Division of Urology
- 吳致瑩 Division of Urology
- Cheng-Che Chen Division of Urology
- 林雁婷 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chao-Hsiang Chang Division of Hematology & Oncology
- Han Chang Division of Others -
- Po-Fan Hsieh Division of Hematology & Oncology
- Chi-Ping Huang Division of Hematology & Oncology
- Wei-Ching Lin Division of Hematology & Oncology
- Po-Jen Hsiao Division of Hematology & Oncology
- Yi-Huei Chang Division of Hematology & Oncology
- Chi-Rei Yang Division of Hematology & Oncology
- 陳冠亨 Division of Hematology & Oncology
- Yu-De Wang Division of Hematology & Oncology
- 謝德鈞 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Hung-Lung Ke Division of Urology
- Shu-Pin Huang Division of Urology
- Ching-Chia Li Division of Urology
- Yung-Chin Lee Division of Urology
- 黃俊農 Division of Urology
- 阮雍順 Division of Urology
- Hsiang Ying Lee Division of Urology
- Sheng-Chen Wen Division of Urology
- Tsu-Ming Chien Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
110 participants
-
Global
2400 participants
